An Update on Kawasaki Disease

Area of Science:

• Pediatric rheumatology
• Immunology
• Epidemiology

Background:

• Kawasaki Disease (KD) is a global systemic inflammatory illness of unknown cause affecting children.
• Understanding KD's epidemiology, pathogenesis, diagnosis, and treatment is crucial.

Purpose of the Study:

• To summarize recent research advancements in Kawasaki Disease.
• To highlight new insights into KD pathogenesis, treatment strategies, and long-term outcomes.

Main Methods:

• Literature review of recent studies on Kawasaki Disease.
• Analysis of epidemiological data, including pandemic effects.
• Evaluation of emerging diagnostic and therapeutic approaches.

Main Results:

• COVID-19 pandemic temporarily reduced KD incidence; NLRP3 inflammasome identified as key in pathogenesis.
• Intensified initial treatment benefits high-risk patients; specific rescue regimens (corticosteroids, infliximab, combination therapy) show promise for refractory KD.
• A new coronary artery aneurysm prediction model shows promise; long-term morbidity and healthcare transition challenges persist.

Conclusions:

• Ongoing research is refining KD treatment and understanding its complex pathogenesis.
• New predictive models and therapeutic strategies are emerging for Kawasaki Disease management.
• Long-term patient care and transition to adult healthcare require further attention.